Avantor, Inc. — Director's Dealing 2022

Feb 26, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Avantor, Inc. (AVTR)
CIK: 0001722482
Period of Report: 2022-02-23

Reporting Person: Brophy Gerard (EVP, Biopharma Production)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-23	Common Stock	S	3059	$33.79	Disposed	125181	Direct
2022-02-23	Common Stock	A	15110	—	Acquired	140291	Direct
2022-02-25	Common Stock	F	2043	$35.39	Disposed	138248	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-23	Stock Options (Right to Buy)	$33.09	A	43708	Acquired	2032-02-23	Common Stock (43708.0)	Direct

Footnotes

F1: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $33.75 to $33.94 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above.

F3: Reflects a grant of restricted stock units that vest in four equal annual installments beginning on February 23, 2023.

F4: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSU's.

F5: Reflects a grant of stock options that vest in four equal annual installments beginning on February 23, 2023.